HIV Vaccines to be Tested at the Disease's Epicenter
Researchers will test four experimental vaccines in a region in South Africa where one in five adults is infected with HIV.
Contributors
Conor Myhrvold
Follow @twitterapi
28 Stories
Contributor
I’m a former editorial intern at MIT Technology Review. Topics I am currently covering include the future of peer-review publishing, science startups, and what technology can tell us about nature, particularly elephants. I graduated from Princeton with an A.B. in Geosciences have completed the master’s program in Science Writing at MIT. I am also a metal aficionado.
Conor Myhrvold's Stories
Topics
- All
- Biomedicine (clear selection)
- Business
- Communications
- Computing
- Web
- Clear Filters
Type
Three Questions for George Whitesides
The Harvard chemist talks about the problem of solving problems.
How Malaria Hijacks Your Immune System
The way the disease tricks the body's defenses could help researchers develop better treatments.
Nanoparticles Deliver Gene Therapy through the Skin
A study suggests that a gene-suppressant could someday be delivered via a cream.
A Kickstarter for Academic Research
The success of "crowd-funding" inspired one researcher to create a Kickstarter-like service for scientists.
Monoclonal Antibody Treatment Shows Promise for Curing Ebola
The virus is tamed in macaques.
Dengue Fever Vaccine In Sight
Sanofi Pasteur's drug enters Phase III trials, bringing the first vaccine a step closer.
Vaccine Could Stop Nicotine from Reaching the Brain
The new antismoking technique uses nanoparticles to trigger an immune response.
- «
- 1
- »
